Granules India gets USFDA approval for capsules to treat ADHD
Granules India gets USFDA approval for capsules to treat ADHD

Granules India gets USFDA approval for capsules to treat ADHD

Apurva Joshi Article rating: 3.0

Granules India Limited’s US subsidiary has received marketing approval from United States Food & Drug Administration (USFDA) for Dexmethylphenidate HCL extended-release capsules for the treatment of attention-deficit/hyperactivity disorder (ADHD).

Indian market may open on soft note following sell-off on Wall Street
Indian market may open on soft note following sell-off on Wall Street

Indian market may open on soft note following sell-off on Wall Street

DSIJ Intelligence-3 Article rating: 4.9

It is said ‘when it rains, it pours’ and this is what the situation of Indian markets is this morning as they received bad news in abundance. To begin with the cues from Wall Street in overnight are fragile as the tech stocks came under hammering and the jobless claims rose more than the estimate.

Nifty trend and stocks in action on September 11, 2020
Nifty trend and stocks in action on September 11, 2020

Nifty trend and stocks in action on September 11, 2020

DSIJ Intelligence-3 Article rating: 4.6

Friday’s session could set the tone for the near term and the level of 11,560-11,570 would hold key importance. Stocks in news:  ITI, TCS, Infosys, Reliance Industries, Indo Count, Motherson Sumi.

Invesco Mutual Fund unveils ‘Focused 20 Equity Fund
Invesco Mutual Fund unveils ‘Focused 20 Equity Fund

Invesco Mutual Fund unveils ‘Focused 20 Equity Fund

DSIJ Intelligence Article rating: 4.0

Invesco Mutual Fund announces the launch of its new fund, Invesco India Focused 20 Equity Fund, an open-ended equity scheme investing in a maximum of 20 stocks across market capitalisation.

Decoding Profitability Ratios
Decoding Profitability Ratios

Decoding Profitability Ratios

DSIJ Intelligence Article rating: 1.7

Companies are in business for one purpose i.e. to make profits. If a company accumulates considerable losses year after year, it will not stay in business for long. Profits are the driving force of growth and also, the main source of repaying loans, making new investments along with providing an adequate return to owners so that they retain their interest and financial backing.

RSS
First27772778277927802782278427852786Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR